CheckMyRecalls

Asclemed USA Inc. recalls Duloxetine DR Capsules

Published
10 Jun 2026
Units affected
50 bottles
Agency
FDA
Country
United States

The hazard

CGMP Deviations; presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the FDA acceptable intake limit.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Duloxetine DR Capsules, 30 mg, 30 count bottles, Rx, Relabeled by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC 76420-634-30, Marketed by: Ajanta Pharma USA Inc.

Brand / company
Asclemed USA Inc.
Codes / lots
Lot # 050725G-30 & 050725F-30, Exp Date: 06/30/2026
Distribution
US Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 10 Jun 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.